Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Creative Medical Technology Holdings (CELZ) Non Operating Income (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Non Operating Income for 13 consecutive years, with $37100.0 as the latest value for Q3 2025.

  • On a quarterly basis, Non Operating Income fell 46.65% to $37100.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $121358.0, a 61.1% decrease, with the full-year FY2024 number at $250380.0, down 24.94% from a year prior.
  • Non Operating Income was $37100.0 for Q3 2025 at Creative Medical Technology Holdings, up from $30217.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $28.1 million in Q1 2021 to a low of -$2.4 million in Q4 2021.
  • A 5-year average of $1.4 million and a median of $61147.0 in 2023 define the central range for Non Operating Income.
  • Biggest YoY gain for Non Operating Income was 590.13% in 2021; the steepest drop was 258.5% in 2021.
  • Creative Medical Technology Holdings' Non Operating Income stood at -$2.4 million in 2021, then soared by 102.59% to $62245.0 in 2022, then skyrocketed by 49.84% to $93265.0 in 2023, then tumbled by 66.05% to $31660.0 in 2024, then grew by 17.18% to $37100.0 in 2025.
  • Per Business Quant, the three most recent readings for CELZ's Non Operating Income are $37100.0 (Q3 2025), $30217.0 (Q2 2025), and $22381.0 (Q1 2025).